EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braun, J.-P.
Right arrow Articles by Liu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braun, J.-P.
Right arrow Articles by Liu, J.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Congenital - acyanotic

Eur J Cardiothorac Surg 2004;26:228-230
© 2004 Elsevier Science NL


Case report

Treatment of acute heart failure in an infant after cardiac surgery using levosimendan

Jan-Peter Brauna*, Martin Schneiderb, Marc Kastrupa, Jianshi Liuc

a Department of Anesthesiology und Intensive Care, Charité University–Hospital, Humboldt University, Schumann Str. 20-21, Berlin D-10117, Germany
b Department of Pediatric Cardiology, Charité University–Hospital, Humboldt University, Berlin, Germany
c Department of Cardiovascular Surgery, Charité University–Hospital, Humboldt University, Berlin, Germany

Received 18 December 2003; received in revised form 1 March 2004; accepted 24 March 2004.

* Corresponding author. Tel.: +49-30-450-531012; fax: +49-30-450-911
e-mail: jan.braun{at}charite.de

An infant, 2 months old, underwent cardiac surgery because of congenital heart defects and pulmonary hypertension. Surgery was performed in hypothermia and cardiac standstill. On the second day after surgery the infant had to be resuscitated due to a combination of acute left-ventricular failure, pulmonary vascular hypertension and a slight right-to-left-shunt. A breakthrough in the treatment was achieved by using levosimendan to improve left-ventricular function and to decrease vascular resistance.

Key Words: Neonatal cardiac surgery • Postoperative resuscitation • Calcium sensitizer • Levosimendan




This article has been cited by other articles:


Home page
Eur Heart JHome page
L. De Luca, W. S. Colucci, M. S. Nieminen, B. M. Massie, and M. Gheorghiade
Evidence-based use of levosimendan in different clinical settings
Eur. Heart J., August 2, 2006; 27(16): 1908 - 1920.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. R. Egan, A. J. B. Clarke, S. Williams, A. D. Cole, J. Ayer, S. Jacobe, R. B. Chard, and D. S. Winlaw
Levosimendan for Low Cardiac Output: A Pediatric Experience.
J Intensive Care Med, May 1, 2006; 21(3): 183 - 187.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. G. Raja and B. S. Rayen
Levosimendan in Cardiac Surgery: Current Best Available Evidence
Ann. Thorac. Surg., April 1, 2006; 81(4): 1536 - 1546.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.